Skip to main content

Table 3 GP-based INR target ranges

From: Differences in the quality of oral anticoagulation therapy with vitamin K antagonists in German GP practices – results of the cluster-randomized PICANT trial (Primary Care Management for Optimized Antithrombotic Treatment)

Range

Patients

(n = 688)

1.5–1.8

1

1.8–2.3

1

1.8–2.9

1

1.8–3

1

2–3

657

2–3.5

2

2–4

10

2.5–3.5

11

2.5–4

3

3–4

1